Literature DB >> 22057492

Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.

Angela Ferrario1, Marian Luna, Natalie Rucker, Sam Wong, Charles J Gomer.   

Abstract

BACKGROUND: A polyphenol constituent of green tea, epigallocatechin gallate (EGCG), has anti-carcinogenic properties. A growing number of studies document EGCG-mediated induction of apoptotic pathways and inhibition of pro-survival factors when combined with chemotherapy or radiation. We evaluated the efficacy of EGCG in modulating photofrin (PH)-mediated photodynamic therapy (PDT) responses.
METHODS: Mouse mammary carcinoma (BA) cells and transplanted BA tumors growing in C3H mice were treated with PH-mediated PDT. Select groups of treated cells and mice also received EGCG and then cytotoxicity, tumor response, and expression of survival molecules were evaluated in all experimental groups.
RESULTS: EGCG increased apoptosis and cytotoxicity in BA cells exposed to PH-mediated PDT. The initial pro-survival phase of the unfolded protein response (UPR), characterized by increased expression of the 78 kDa glucose-regulated protein (GRP-78), was induced by PDT. The second pro-apoptotic phase of the UPR, characterized by phospho-c-Jun N-terminal kinase (p-JNK) expression, activation of caspases-3 and 7, poly ADP ribose polymerase (PARP) cleavage, and expression of C/EBP homologous protein was observed when PDT was combined with EGCG. EGCG also decreased the expression of the pro-survival proteins GRP-78 and survivin, and attenuated PDT-induced prostaglandin E2 (PGE2 ) expression in PDT-treated cells. Comparable responses also were observed when BA tumors were treated with PDT and EGCG. In addition, PDT-induced expression of metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) was down-regulated in treated tumor tissue by EGCG.
CONCLUSIONS: The polyphenol EGCG improves PDT efficacy by increasing tumor apoptosis and decreasing expression of pro-survival and angiogenic molecules within the tumor microenvironment.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057492      PMCID: PMC3211098          DOI: 10.1002/lsm.21081

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  30 in total

Review 1.  Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.

Authors:  Charles J Gomer; Angela Ferrario; Marian Luna; Natalie Rucker; Sam Wong
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

2.  Fold up or perish: unfolded protein response and chemotherapy.

Authors:  A Strasser; H Puthalakath
Journal:  Cell Death Differ       Date:  2007-11-30       Impact factor: 15.828

3.  Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model.

Authors:  Angela Ferrario; Charles J Gomer
Journal:  J Environ Pathol Toxicol Oncol       Date:  2006       Impact factor: 3.567

4.  (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.

Authors:  Svetlana P Ermakova; Bong Seok Kang; Bu Young Choi; Hong Seok Choi; Todd F Schuster; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

5.  Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.

Authors:  I A Siddiqui; A Malik; V M Adhami; M Asim; B B Hafeez; S Sarfaraz; H Mukhtar
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

6.  Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage.

Authors:  David Kessel; John J Reiners
Journal:  Photochem Photobiol       Date:  2007 Sep-Oct       Impact factor: 3.421

Review 7.  Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

Authors:  Naghma Khan; Farrukh Afaq; Mohammad Saleem; Nihal Ahmad; Hasan Mukhtar
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

8.  The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

Authors:  Peter Pyrko; Axel H Schönthal; Florence M Hofman; Thomas C Chen; Amy S Lee
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

9.  Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.

Authors:  Angela Ferrario; Natalie Rucker; Sam Wong; Marian Luna; Charles J Gomer
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

Review 10.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

Authors:  Esther Buytaert; Michael Dewaele; Patrizia Agostinis
Journal:  Biochim Biophys Acta       Date:  2007-07-06
View more
  6 in total

Review 1.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

Review 2.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

3.  GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy.

Authors:  M Firczuk; M Gabrysiak; J Barankiewicz; A Domagala; D Nowis; M Kujawa; E Jankowska-Steifer; M Wachowska; E Glodkowska-Mrowka; B Korsak; M Winiarska; J Golab
Journal:  Cell Death Dis       Date:  2013-07-25       Impact factor: 8.469

4.  Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.

Authors:  Daniela León; Kurt Buchegger; Ramón Silva; Ismael Riquelme; Tamara Viscarra; Bárbara Mora-Lagos; Louise Zanella; Fabiola Schafer; Cristina Kurachi; Juan Carlos Roa; Carmen Ili; Priscilla Brebi
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

Review 5.  Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.

Authors:  Nicholas J Collier; Lesley E Rhodes
Journal:  Molecules       Date:  2020-11-18       Impact factor: 4.411

6.  Enhancement of Phthalocyanine Mediated Photodynamic Therapy by Catechin on Lung Cancer Cells.

Authors:  Giftson J Senapathy; Blassan P George; Heidi Abrahamse
Journal:  Molecules       Date:  2020-10-22       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.